News from cytosorbents corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( OTC-BB:CTSO)

Feb 04, 2016, 07:00 ET
CytoSorbents Logo.

CytoSorbents to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to...

Feb 01, 2016, 07:00 ET
CytoSorbents Logo. (PRNewsFoto/CytoSorbents)

CytoSorbents Receives $325,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to...

Jan 28, 2016, 07:00 ET
CytoSorbents Logo. (PRNewsFoto/CytoSorbents)

CytoSorbents to Present at the 18th Annual BIO CEO & Investor Conference

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to...

Jan 21, 2016, 08:00 ET
CytoSorbents Logo. (PRNewsFoto/CytoSorbents)

CytoSorbents Appoints Dr. Volker Humbert as Senior Manager of Clinical Affairs

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its European Union approved CytoSorb® blood...

Jan 11, 2016, 08:00 ET
CytoSorbents Logo.

CytoSorbents 2016 - Driving Toward the Inflection Point

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb®...

Jan 04, 2016, 07:00 ET
CytoSorbents Logo.

CytoSorbents To Present at Biotech Showcase 2016

 CytoSorbents Corporation (NASDAQ: CTSO) announced that Dr. Phillip Chan, MD, PhD, Chief Executive Officer, will present at the Biotech...

Dec 21, 2015, 10:22 ET
CytoSorbents Logo.

CytoSorbents Issues EAP Update

CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy commercializing its CytoSorb® extracorporeal cytokine...

Dec 15, 2015, 07:00 ET
CytoSorbents Logo

CytoSorbents Expands Distribution of CytoSorb® to Vietnam

 CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy commercializing its CytoSorb® extracorporeal cytokine...

Dec 09, 2015, 08:30 ET
CytoSorbents Logo

CytoSorbents to Ring Opening Bell to Celebrate One Year NASDAQ Anniversary

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology...

Dec 01, 2015, 15:39 ET
CytoSorbents

CytoSorbents to Participate in Upcoming Investor Conferences

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader, commercializing its CytoSorb® blood purification...

Nov 13, 2015, 08:00 ET
CytoSorbents Logo.

CytoSorbents Accelerates Growth in Q3 2015

CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy commercializing its CytoSorb® blood purification technology...

Nov 09, 2015, 09:19 ET
CytoSorbents Logo.

CytoSorbents To Meet With Investors at Brean Capital Life Sciences Summit and Stifel 2015 Healthcare Conference

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine...

Nov 06, 2015, 08:00 ET
CytoSorbents Logo.

CytoSorbents to Report Q3 2015 Operating and Financial Results

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine...

Oct 27, 2015, 08:30 ET
CytoSorbents Logo

CytoSorbents To Advance HemoDefend™ Towards Commercialization with $1.5 Million Phase II SBIR Contract from NHLBI/NIH

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy company specializing in blood purification, announced today that the...

Oct 05, 2015, 10:37 ET
CytoSorbents Logo

CytoSorbents Reports CytoSorb® Usage Grows to 8,000+ Human Treatments at Successful Second International Users Meeting

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification...

Sep 30, 2015, 08:00 ET
CytoSorbents Logo.

CytoSorbents Ready for Second International CytoSorb® Users Meeting, ESICM and EACTS Conferences

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology...

Sep 14, 2015, 09:00 ET
CytoSorbents Logo.

World Sepsis Day 2015: CytoSorbents Sponsors the SepsisUpdate 2015 Congress, Hugo Schottmuller Prize, and Sepsis Heroes Ceremony

CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy using its CytoSorb® blood purification technology to help...

Sep 02, 2015, 07:00 ET
CytoSorbents Logo.

CytoSorbents to Present at the 2015 Rodman & Renshaw Annual Global Investment Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to...

Aug 13, 2015, 16:15 ET
CytoSorbents Logo.

CytoSorbents Reports Steady Growth in Q2 2015

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to...

Aug 10, 2015, 08:00 ET
CytoSorbents Logo.

Saudi Food and Drug Authority Approves CytoSorb®

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine...